231 related articles for article (PubMed ID: 37188336)
1. Mechanistic Insights into Harmine-Mediated Inhibition of Human DNA Methyltransferases and Prostate Cancer Cell Growth.
Cho CC; Lin CJ; Huang HH; Yang WZ; Fei CY; Lin HY; Lee MS; Yuan HS
ACS Chem Biol; 2023 Jun; 18(6):1335-1350. PubMed ID: 37188336
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel non-nucleoside inhibitors with high potency and selectivity for DNA methyltransferase 3A.
Yu J; Chai X; Pang J; Wang Z; Zhao H; Xie T; Xu L; Sheng R; Li D; Zeng S; Hou T; Kang Y
Eur J Med Chem; 2022 Nov; 242():114646. PubMed ID: 36029561
[TBL] [Abstract][Full Text] [Related]
3. Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells.
Agarwal S; Amin KS; Jagadeesh S; Baishay G; Rao PG; Barua NC; Bhattacharya S; Banerjee PP
Mol Cancer; 2013 Aug; 12(1):99. PubMed ID: 24001151
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase.
Benbrahim-Tallaa L; Waterland RA; Dill AL; Webber MM; Waalkes MP
Environ Health Perspect; 2007 Oct; 115(10):1454-9. PubMed ID: 17938735
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a.
Liu WB; Cui ZH; Ao L; Zhou ZY; Zhou YH; Yuan XY; Xiang YL; Liu JY; Cao J
Toxicol Appl Pharmacol; 2011 Feb; 251(1):70-8. PubMed ID: 21163286
[TBL] [Abstract][Full Text] [Related]
6. DNMT3L stimulates the DNA methylation activity of Dnmt3a and Dnmt3b through a direct interaction.
Suetake I; Shinozaki F; Miyagawa J; Takeshima H; Tajima S
J Biol Chem; 2004 Jun; 279(26):27816-23. PubMed ID: 15105426
[TBL] [Abstract][Full Text] [Related]
7. Pivotal role for S-nitrosylation of DNA methyltransferase 3B in epigenetic regulation of tumorigenesis.
Okuda K; Nakahara K; Ito A; Iijima Y; Nomura R; Kumar A; Fujikawa K; Adachi K; Shimada Y; Fujio S; Yamamoto R; Takasugi N; Onuma K; Osaki M; Okada F; Ukegawa T; Takeuchi Y; Yasui N; Yamashita A; Marusawa H; Matsushita Y; Katagiri T; Shibata T; Uchida K; Niu SY; Lang NB; Nakamura T; Zhang KYJ; Lipton SA; Uehara T
Nat Commun; 2023 Feb; 14(1):621. PubMed ID: 36739439
[TBL] [Abstract][Full Text] [Related]
8. DNA Methyltransferase Inhibitors and their Therapeutic Potential.
Zhou Z; Li HQ; Liu F
Curr Top Med Chem; 2018; 18(28):2448-2457. PubMed ID: 30465505
[TBL] [Abstract][Full Text] [Related]
9. DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells.
Kim H; Park J; Jung Y; Song SH; Han SW; Oh DY; Im SA; Bang YJ; Kim TY
Int J Oncol; 2010 Jun; 36(6):1563-72. PubMed ID: 20428781
[TBL] [Abstract][Full Text] [Related]
10. Genetic Studies on Mammalian DNA Methyltransferases.
Dan J; Chen T
Adv Exp Med Biol; 2022; 1389():111-136. PubMed ID: 36350508
[TBL] [Abstract][Full Text] [Related]
11. DNMT1, DNMT3A and DNMT3B proteins are differently expressed in mouse oocytes and early embryos.
Uysal F; Ozturk S; Akkoyunlu G
J Mol Histol; 2017 Dec; 48(5-6):417-426. PubMed ID: 29027601
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas.
Rajendran G; Shanmuganandam K; Bendre A; Muzumdar D; Goel A; Shiras A
J Neurooncol; 2011 Sep; 104(2):483-94. PubMed ID: 21229291
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts.
Casillas MA; Lopatina N; Andrews LG; Tollefsbol TO
Mol Cell Biochem; 2003 Oct; 252(1-2):33-43. PubMed ID: 14577574
[TBL] [Abstract][Full Text] [Related]
14. DNA methyltransferase and demethylase in human prostate cancer.
Patra SK; Patra A; Zhao H; Dahiya R
Mol Carcinog; 2002 Mar; 33(3):163-71. PubMed ID: 11870882
[TBL] [Abstract][Full Text] [Related]
15. DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer.
Singh V; Sharma P; Capalash N
Curr Cancer Drug Targets; 2013 May; 13(4):379-99. PubMed ID: 23517596
[TBL] [Abstract][Full Text] [Related]
16. Enzymology of Mammalian DNA Methyltransferases.
Jurkowska RZ; Jeltsch A
Adv Exp Med Biol; 2022; 1389():69-110. PubMed ID: 36350507
[TBL] [Abstract][Full Text] [Related]
17. DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modifications in colon cancer.
Jin B; Yao B; Li JL; Fields CR; Delmas AL; Liu C; Robertson KD
Cancer Res; 2009 Sep; 69(18):7412-21. PubMed ID: 19723660
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells.
Graça I; Sousa EJ; Baptista T; Almeida M; Ramalho-Carvalho J; Palmeira C; Henrique R; Jerónimo C
Curr Pharm Des; 2014; 20(11):1803-11. PubMed ID: 23888969
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of motor neuron cell death through DNA methylation.
Chestnut BA; Chang Q; Price A; Lesuisse C; Wong M; Martin LJ
J Neurosci; 2011 Nov; 31(46):16619-36. PubMed ID: 22090490
[TBL] [Abstract][Full Text] [Related]
20. DNA methyltransferases in hematological malignancies.
Hoang NM; Rui L
J Genet Genomics; 2020 Jul; 47(7):361-372. PubMed ID: 32994141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
